Disproportionality analysis to investigate fatal adverse events with immune checkpoint inhibitors: Proceed with extreme caution

Proceedings of the National Academy of Sciences 2026 Open access

Read full text

Authors: Bruno Revol, Charles Khouri, Emanuel Raschi

DOI: 10.1073/pnas.2608648123

Cited by: 1

References: 8

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers CAR-T cell therapy research Immunodeficiency and Autoimmune Disorders

References 8